Cardiovascular Systems Inc. (CSII)

44.32
NASDAQ : Health Technology
Prev Close 44.48
Day Low/High 44.01 / 44.88
52 Wk Low/High 24.84 / 46.52
Avg Volume 278.20K
Exchange NASDAQ
Shares Outstanding 34.83M
Market Cap 1.55B
EPS 0.10
P/E Ratio 741.33
Div & Yield N.A. (N.A)
MKM Partners' 4 Health Care Stocks to Sell Before June

MKM Partners' 4 Health Care Stocks to Sell Before June

June has historically been one of the weakest months for equities, which means stock selection -- both buying and selling -- will be critical over the short term.

Cardiovascular Systems is Now Oversold (CSII)

Cardiovascular Systems is Now Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems Peripheral And Coronary Data Featured At EuroPCR 2015

Cardiovascular Systems Peripheral And Coronary Data Featured At EuroPCR 2015

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education and advancement of medical technologies, presented...

New Journal Article Highlights Mechanical Effects Of Orbital Atherectomy And Rotational Atherectomy In Treating Heavily Calcified Coronary Lesions

New Journal Article Highlights Mechanical Effects Of Orbital Atherectomy And Rotational Atherectomy In Treating Heavily Calcified Coronary Lesions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that a new article e-published in May 2015 in The Journal of Catheterization and Cardiovascular Intervention highlights the mechanical effect of orbital...

Commit To Purchase Cardiovascular Systems At $25, Earn 8.6% Annualized Using Options

Commit To Purchase Cardiovascular Systems At $25, Earn 8.6% Annualized Using Options

Investors eyeing a purchase of Cardiovascular Systems, Inc shares, but tentative about paying the going market price of $30.80/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $25 strike, which has a bid at the time of this writing of $1.30.

Cardiovascular Systems Features Two-Year ORBIT II Coronary Data And Long-Term Economic Data In Late-Breaking Presentation At SCAI 2015 Scientific Sessions

Cardiovascular Systems Features Two-Year ORBIT II Coronary Data And Long-Term Economic Data In Late-Breaking Presentation At SCAI 2015 Scientific Sessions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), featured two-year data from its ORBIT II study of the company's Diamondback 360 ® Coronary Orbital Atherectomy System (OAS), the only U.

Insider Trading Alert - HELE, CSII And GOOD Traded By Insiders

Insider Trading Alert - HELE, CSII And GOOD Traded By Insiders

Stocks with insider trader activity include HELE, CSII and GOOD

Cardiovascular Systems To Feature ORBIT II Two-Year And Long-Term Economic Data In Late-Breaking Presentation At The SCAI 2015 Scientific Sessions

Cardiovascular Systems To Feature ORBIT II Two-Year And Long-Term Economic Data In Late-Breaking Presentation At The SCAI 2015 Scientific Sessions

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), will feature two-year results from its ORBIT II trial as well as a long-term economic analysis of the company's Diamondback 360 ® Coronary Orbital Atherectomy System...

Cardiovascular Systems (CSII) Is Weak On High Volume Today

Cardiovascular Systems (CSII) Is Weak On High Volume Today

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a weak on high relative volume candidate

Cardiovascular Systems Reports Fiscal 2015 Third-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2015 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems Receives FDA Clearance For New Peripheral Diamondback Device

Cardiovascular Systems Receives FDA Clearance For New Peripheral Diamondback Device

Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), announced today that it has received FDA clearance for the new 4 French (4 Fr) 1.

Cardiovascular Systems To Webcast Fiscal 2015 Third-Quarter Earnings Conference Call Wednesday, April 29

Cardiovascular Systems To Webcast Fiscal 2015 Third-Quarter Earnings Conference Call Wednesday, April 29

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2015 third-quarter conference call on Wednesday, April 29, 2015, at 3:45 p.

Cardiovascular Systems To Present At Barclays 2015 Global Healthcare Conference

Cardiovascular Systems To Present At Barclays 2015 Global Healthcare Conference

On Wednesday, March 11, 2015, Cardiovascular Systems' (NASDAQ: CSII) President and Chief Executive Officer, David L.

Insider Trading Alert - RCL, CSII And WR Traded By Insiders

Insider Trading Alert - RCL, CSII And WR Traded By Insiders

Stocks with insider trader activity include RCL, CSII and WR

Insider Trading Alert - TJX, CSII And PDFS Traded By Insiders

Insider Trading Alert - TJX, CSII And PDFS Traded By Insiders

Stocks with insider trader activity include TJX, CSII and PDFS

Insider Trading Alert - CSII, GM And HYGS Traded By Insiders

Insider Trading Alert - CSII, GM And HYGS Traded By Insiders

Stocks with insider trader activity include CSII, GM and HYGS

Cardiovascular Systems Releases Two-Year ORBIT II Coronary Data In Late-Breaking Presentation At 2015 Cardiovascular Research Technologies Conference

Cardiovascular Systems Releases Two-Year ORBIT II Coronary Data In Late-Breaking Presentation At 2015 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), released two-year data from its ORBIT II study of the company's Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) in treating severely calcified lesions in a...

Modification Of Atherosclerotic Plaque With Diamondback 360 Orbital Atherectomy Device Improved Drug Uptake In Peripheral Arteries In A Preclinical Study

Modification Of Atherosclerotic Plaque With Diamondback 360 Orbital Atherectomy Device Improved Drug Uptake In Peripheral Arteries In A Preclinical Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today announced that CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, disclosed...

Cardiovascular Systems To Present ORBIT II Two-Year Coronary Data At 2015 Cardiovascular Research Technologies Conference

Cardiovascular Systems To Present ORBIT II Two-Year Coronary Data At 2015 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), will release two-year data from its ORBIT II study of the company's Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) in treating severely calcified lesions...

Insider Trading Alert - HCA, FMI And CSII Traded By Insiders

Insider Trading Alert - HCA, FMI And CSII Traded By Insiders

Stocks with insider trader activity include HCA, FMI and CSII

Insider Trading Alert - SCTY, FBIZ And CSII Traded By Insiders

Insider Trading Alert - SCTY, FBIZ And CSII Traded By Insiders

Stocks with insider trader activity include SCTY, FBIZ and CSII

Cardiovascular Systems (CSII) Is Strong On High Volume Today

Cardiovascular Systems (CSII) Is Strong On High Volume Today

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a strong on high relative volume candidate

Cardiovascular Systems Reports Fiscal 2015 Second-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2015 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems To Webcast Fiscal 2015 Second-Quarter Earnings Conference Call Wednesday, January 28

Cardiovascular Systems To Webcast Fiscal 2015 Second-Quarter Earnings Conference Call Wednesday, January 28

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2015 second-quarter conference call on Wednesday, January 28, 2015, at 3:45 p.

Cardiovascular Systems Completes Coast Study Enrollment In Japan

Cardiovascular Systems Completes Coast Study Enrollment In Japan

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that it has completed enrollment in Japan for its Coronary Orbital Atherectomy System Trial (COAST) study.

Cardiovascular Systems Receives CE Mark For Stealth 360® Peripheral Orbital Atherectomy System

Cardiovascular Systems Receives CE Mark For Stealth 360® Peripheral Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has received CE (Conformité Européenne) Mark for its Stealth 360º Orbital Atherectomy System (OAS).

Cardiovascular Systems Reports Fiscal 2015 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2015 First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported...

Cardiovascular Systems Enrolls First Seven Patients In Japan For Coast Study

Cardiovascular Systems Enrolls First Seven Patients In Japan For Coast Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study.

Cardiovascular Systems To Webcast Fiscal 2015 First-Quarter Earnings Conference Call Wednesday, October 29

Cardiovascular Systems To Webcast Fiscal 2015 First-Quarter Earnings Conference Call Wednesday, October 29

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2015 first-quarter conference call on Wednesday, October 29, 2014, at 3:45 p.

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: C (Hold)